Simplera™ CGM Accuracy in Diabetes Patients on Icodextrin Peritoneal Dialysis

This study focuses on evaluating the accuracy of a specific continuous glucose monitoring system, the Medtronic Simplera™ CGM. The study involves diabetes patients who are undergoing a type of dialysis known as peritoneal dialysis, which uses a solution containing icodextrin. The main goal is to compare the performance of the Simplera™ CGM to a gold standard reference laboratory method for measuring glucose levels, called YSI glucose. This research is important as it aims to ensure the reliability of the Simplera™ CGM in this specific patient population, potentially improving their glucose management and overall care. During the study, participants will use the Simplera™ CGM while continuing their regular peritoneal dialysis regimen. The CGM system will monitor their glucose levels continuously. These results will then be compared with the results obtained from the YSI glucose method, which is currently considered a highly accurate way to measure glucose. The primary outcome of the study is to calculate the mean absolute relative difference (MARD) between the glucose readings from the Simplera™ CGM and the YSI glucose method. This comparison will help determine how closely the CGM readings match the YSI readings, indicating the accuracy of the Simplera™ CGM system.